Discover
NGEN
NervGen Pharma Corp. Common stock
1.78
17 x 1.74
1 x 1.97
bid
ask
+
0.05
2.89%
15 @ 04:00 PM
1.74 -0.04 (2.25%)
| Ytd | -70.18% | |
| 1y | -70.18% |
1.74
day range
1.84
1.59
52 week range
6.30
| Open | 1.75 | Prev Close | 1.73 | Low | 1.74 | High | 1.84 | Mkt Cap | 146.30M |
| Vol | 680.69K | Avg Vol | 922.67K | EPS | -0.27 | P/E | -6.53 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-18 | 50-d Avg | 2.29 | 200-d Avg | 3.53 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 7.53M | ||
| Research and Development Expense | 4.86M | ||
| Selling, General and Administrative Expense | 2.67M | ||
| Operating Income | -7.53M | ||
| Net Income | -1.68M | ||
| Net Income Common Stock | -1.68M | ||
| Net Income Common Stock (USD) | -1.21M | ||
| Consolidated Income | -1.68M | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.01 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -1.68M | ||
| Earning Before Interest & Taxes (USD) | -1.21M | ||
| Weighted Average Shares | 79.90M | ||
| Weighted Average Shares Diluted | 79.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 16.56M | ||
| Cash and Equivalents (USD) | 12.00M | ||
| Trade and Non-Trade Receivables | 93.54K | ||
| Current Assets | 20.37M | ||
| Total Assets | 20.77M | ||
| Current Liabilities | 15.22M | ||
| Total Liabilities | 15.22M | ||
| Accumulated Retained Earnings (Deficit) | -148.44M | ||
| Shareholders Equity | 5.54M | ||
| Shareholders Equity (USD) | 4.02M | ||
| Assets Non-Current | 395.21K | ||
| Goodwill and Intangible Assets | 395.21K | ||
| Trade and Non-Trade Payables | 5.88M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.95K | ||
| Net Cash Flow from Financing | 2.78M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.51M | ||
| Issuance (Purchase) of Equity Shares | 2.79M | ||
| Issuance (Repayment) of Debt Securities | -8.41K | ||
| Net Cash Flow from Investing | 8.41K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.41K | ||
| Net Cash Flow from Operations | -8.20M | ||
| Effect of Exchange Rate Changes on Cash | -98.99K | ||
| Share Based Compensation | 952.13K | ||